Within the next decade, the size of the Alzheimer’s disease (AD) diagnostics and biomarkers market will overtake the market for currently available AD treatments, with an anticipated annual market val
Company Changes BARR , John To: Angiotech Pharmaceuticals Inc. , CEO (October) From: Bausch & Lomb Inc., EVP, Pres., Global Surgical Phone: 604-221-7676 BARTHELEMY , Nicolas To: bioTheranos
IN VITRO DIAGNOSTICS InSilixa Inc. InSilixa raises $13mm in early-stage round Molecular diagnostics start-up InSilixa Inc. raised $13mm in an early-stage financing led by PointGuard Ventures a